The leukocyte counts of patients with CALR mutations were lower than those of patients with JAK2 V617F mutations, but the difference did not reach statistical significance (8.9x10 9 /L [range: 3.4-20.6x10 9 /L] vs. 9.8x10 9 /L [range: 3.9-33.3x10 9 /L], p=0.06).
← all excerpts
Impact of <i>CALR</i> and <i>JAK2</i>V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.
1
0.0600
0.0600